Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
i have 411,155 at .0245 and it hasn,t filled.maybe a good sign?we need news?
3hrs with no trades.... where's the interest? Asking for a friend
I see your order sitting. Great Bid support.
put a order in for 433,990 at .0245 22,845 got filled.the good thing here it should not drop below .0245 still have 411,155 to fill.good luck to all longs.i hope order doesn't fill i what this to finaly go up.
Need the trifecta of amateur sleuths on this one Turbo. Call in the full gambit of detectives:
Hardy Boys, Nancy Drew, Scooby & Shaggy, MatLock, Angela Lansbury, Mariska Hargitay, The Man in the Yellow Hat and Columbo for good measure!!
Looks like we need the help of the hardly boys to solve this quiet period mystery
Tin Foil Hats... Check!
Pocket Protector... Check!
Cheese Balls... Check!
Nipple Clamps for Jay... OUCH!!
Everyone get out your tin foil hats, we are looking for clues in the share trading history
It's a code MrMike
That’s what they mean...guess we’ll see
That is well known to be the worst case possibility.
Good Luck to Us!
Go RXMD!
Brilliant!!!!!!!!!!!!
I miss those $69 trades now......what a reminder!
Maybe that long awaited “ Letter to the Shareholders “ with answers. Go RXMD
Are you saying this might go on this way till February?
If real (not a retail gamer) 911 means pending news
I hadn't noticed that, but the 911's are in the trade data today!
Hope!
Go RXMD!
Sounds like a troll.
What was weird about today’s trading was the unusual high number of 911 trades. I don’t know if they mean anything but there were several of them.
Yes. Maybe we will...
I would love to hear that news officially. Maybe I will, soon?
Go RXMD!
The purpose of the offering is to raise the funds to pay off debt, expand, etc. completely separate from the uplist. I think they are close...the next couple of weeks should tell.
Well, that is very interesting, it could explain the current situation. I hope we find out before July! Technically, they have until February.
I wonder if they're close or not. Hopefully that is what Jay and ClearThink have been doing!
Go RXMD!
Great point Mike. They are separate events and Yes the offering can be completed before the uplist.
I was reviewing the S-1 incentive wording, link below.
"Should the current offering be completed, it will be considered a qualified offering pursuant to the terms of the agreement."
I notice it doesn't say Uplist. It says Offering.
Maybe the uplist and the offering are separate. Can the offering be completed before the uplist? Could it be announced unexpectedly?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169217963
Baaaahahahahhaha!! Very clever and 100% correct my friend. That was brilliant!! Kudos on the word play. LMFAO
Who needs an iceberg when you have a Weisberg as your captain of the ship.
Over the last 45 minutes of trading today someone sold approximately 200,000 shares on the bid. That’s what dropped the SP late today.
I suspect theres ALOT of friction and animosity at RXMD headquarters based on Jay's performance; or lack there of in reality. Every insider is deep underwater with no signs of a life ring in sight.
Queue that beautiful Titantic Orchestra music, just a continuous decline day after day. The iceberg of note conversions will soon resume and that will upset more than just insiders.
"Hey Ho, Jay's Gotta Go!! What do need, Ms. Mars... When do we need her...NOW!!" LOL
Down another 8% unless someone buys 50-shares at 3:59pm...lol
58k-buys
250k-sells
Where are the buyers at this great price?
I was wondering who that was. I'm looking at .0005-0009 But the way this is going, you might get .003
Pl don’t sell at .004. Lmao
No …. Just 003 for 500k
Let me guess .019?
No disrespect to you Gedi, the only joker here is the temporary CEO. Jay has got us to the point we can’t take this to the bank because there’s no Interest here.
What I said was laughable in my post that you commented on was the fact that for 2 straight days someone sold less than $5.00 worth of stock to start the trading day. And each of these $5.00 sells were at the low of the day.
Thats a good one.
Yeah we’re all laughing all the way to the TANK
That's a good one also Capt. I was thinking about that also. You and Turbo crack me up! The BOD pisses me off! What a joke they turned this company into!!!
I'm with you my Friend.
Yes. I saw that yesterday at opening bell also, let's see if we bounce off this low and end these Reindeer Games. LOL
Someone is playing games Capt. That was a $4.62 trade. The commission for that trade costs more than the trade. Someone did exactly the same yesterday morning.
Absolutely laughable.
Hit 52 week low at opening bell.... BRILLIANT!!
Great job two year temporary CEO; pat yourself on the back. Taking the 5th on investor relations was not the smartest move Sleepy Jay.
Better yet, give yourself a swift kick out the door. Jay has done nothing to draw value investors to RXMD like Ms. Shital Mars did. Hasn't even attended a single investor conference since take his "temporary" role.
CEO = Useless POS
NASDAQ IPOs are at an all time low during the current declining market conditions. What makes RXMD management think they are so special and can survive an uplist now with NASDAQ down over 30% from last year's high.
Incentives or not, uplisting would be disastrous anytime this summer as they forecasted during last conference call.
Their head in the clouds management practices are going to be their Achilles Heel.
This post needs to be pined up on the board.
Followers
|
746
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
196172
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |